The Chicago Entrepreneur

Dow Jones Newswires: GlaxoSmithKline to buy Sierra Oncology for $1.9 billion

Pharmaceutical giant GlaxoSmithKline PLC said Wednesday that it is buying biopharmaceutical company Sierra Oncology Inc. for $1.9 billion, and backed its guidance.

Previous post Dow Jones Newswires: Tesco profit jumps as revenue rises faster than forecast
Next post Dow Jones Newswires: U.K. inflation accelerates to three-decade high in March